This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biotechnology. Top assignees: Intercell Ag, Valneva Austria Gmbh, Intercell Austria Ag. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vienna, AT (2008 - 2013)
- Pressbaum, AT (2012 - 2022)
Company Filing History:
9 out of 36 
9 out of 46 
1 out of 2 Years Active: 2008-2025
Areas of Expertise:
Title: Celebrating the Innovations of Markus Hanner
Introduction
Markus Hanner is an accomplished inventor based in Pressbaum, Austria, renowned for his contributions to the field of biotechnology. With 19 patents to his name, he has made significant advancements in the development of therapeutic agents, particularly focusing on the outer surface protein A (OspA). His work exemplifies the intersection of innovation and healthcare, driving forward new methodologies for disease prevention and treatment.
Latest Patents
One of Markus Hanner's latest inventions is centered around "Mutant fragments of OspA and methods and uses relating thereto." This invention involves a polypeptide comprising a mutant fragment of OspA, along with a corresponding nucleic acid. The pharmaceutical composition stemming from this breakthrough is aimed at treating or preventing infections, highlighting its potential for medicinal applications. Furthermore, the invention includes methods of immunizing subjects, marking a substantial contribution to therapeutic practices in the medical field.
Career Highlights
Throughout his career, Markus Hanner has worked at leading biotechnology firms, including Intercell AG and Valneva Austria GmbH. His experiences in these esteemed companies have fortified his expertise and propelled his research pursuits, allowing him to make remarkable contributions to innovation in biotech therapeutics.
Collaborations
Markus has collaborated with several talented professionals, including Andreas Meinke and Eszter Nagy. These partnerships have played a crucial role in advancing his research initiatives and fostering an environment of collaborative invention.
Conclusion
Markus Hanner stands out as a prominent inventor in the realm of biotechnology, with a passion for creating solutions that address pressing medical challenges. His numerous patents reflect a commitment to innovation and a future where disease prevention and treatment can be enhanced through scientific discovery. With ongoing collaborations and a rich professional background, Markus continues to inspire upcoming generations of inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile